• Publications
  • Influence
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
The final clinical practice guidelines and recommendations for the optimal management of chronic HBV infection are presented here, along with the relevant background information. Expand
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
New HBV management guidelines include general management, indications for fibrosis assessment, time to start or stop drug therapy, choice of drug to initiate therapy, when and how to monitor the patients during and after stopping drug therapy. Expand
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
Recommendations on the management of hepatocellular carcinoma were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference. Expand
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.
Judging from higher survival but similar adverse events, radiofrequency ablation is superior to ethanol injection for small hepatocellular carcinoma. Expand
Standard steroid treatment for autoimmune pancreatitis
The major indication for steroid treatment in AIP is the presence of symptoms, and an initial prednisolone dose of 0.6 mg/kg/day, is recommend, which is then reduced to a maintenance dose over a period of 3–6 months. Expand
Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan
An analysis of the effect of interferon therapy on the incidence and prevention of hepatocellular carcinoma in patients with chronic hepatitis C who have undergone liver biopsy at one of eight participating institutions supported by the Japan Ministry of Health and Welfare. Expand
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
The latest guidelines for the treatment of HCC recommend evidence-based management and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments. Expand
Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan †
  • I. Ikai, S. Arii, +9 authors M. Kudo
  • Medicine
  • Hepatology research : the official journal of the…
  • 1 September 2007
The cumulative survival rates of newly registered patients in the 12th to 17th follow‐up surveys conducted between 1992 and 2003 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified by background factors and treatment. Expand
Functional analysis of PIK3CA gene mutations in human colorectal cancer.
Results show that almost all the colon cancer-associated PIK3CA mutations are functionally active so that they are likely to be involved in carcinogenesis. Expand
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
TACE showed safe therapeutic modality with a 5-year survival of 26% for unresectable HCC patients and both the degree of liver damage and the tumor-node-metastasis (TNM) system proposed by the Liver Cancer Study Group of Japan demonstrated good stratification of survivals. Expand